RARECAUTIOUS

Debt-to-Equity Ratio

-5.08x

Higher than 0% of Healthcare sector peers

Updated 1079h ago

Sector Performance

0th percentile

RARE

-5.08x

Sector Median

0.43x

Sector Avg

0.81x

📊

Deep Analysis

A debt-to-equity ratio compares a company’s total liabilities to its shareholders’ equity; a negative value like -5.08x means Ultragenyx has more debt than the book value of its equity, effectively indicating negative equity on the balance sheet.

This places the company at the 0th percentile among healthcare peers, far below the sector median of 0.45x, where most competitors use moderate leverage. Trend data is not available—year-over-year and quarter-over-quarter changes are both marked as N/A, and the last eight quarters show no historical progression to evaluate. The combination of an extremely negative ratio and no trend history signals that the company is in a highly distressed capital structure, which raises substantial risk of financial instability or even insolvency. This metric directly supports the cautious overall verdict, as a negative equity position is a clear red flag for investors and contradicts any bullish outlook.

Frequently Asked Questions

What does the Debt-to-Equity Ratio tell investors about RARE?

Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.

How is the Debt-to-Equity Ratio calculated?

Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.

How does RARE's Debt-to-Equity Ratio compare to its sector?

RARE's Debt-to-Equity Ratio of -5.08x compares to a Healthcare sector median of 0.43x, placing it in the 0th percentile.

Who are RARE's closest peers by Debt-to-Equity Ratio?

The closest Healthcare peers by Debt-to-Equity Ratio include: BSX (0.43x), BIIB (0.34x), BIO (0.18x), NTRA (0.14x), NTLA (0.13x).

The Formula

Total Debt / Shareholders' Equity

Why It Matters

Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.

Master RARE's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full RARE research report

Free account — no credit card

RARE

-5.08x

Sector Median

0.43x

Sector Avg

0.81x

How RARE's Debt-to-Equity Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.